News & events
Q-linea announces new organisation and changes in executive leadership team
Q-linea announces FDA submission for expanded claims for ASTar® BC G- panel
Q-linea AB (publ) (OMX: QLINEA) today announces their FDA 510(k) submission for expanded organism and antimicrobial claims on their...
Read more >
Q-linea resolves to carry out a directed issue of shares to a guarantor in connection with the completed preferential rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces that the Company's board, with the support of...
Read more >
Q-linea announces outcome of rights issue
Q-linea AB (publ) (”Q-linea” or the “Company”) (Nasdaq Stockholm: QLINEA) announces the outcome of the Company’s rights issue of...
Read more >
Q-linea announces cost efficiency program to accelerate sales and marketing activities
Driven by Q-linea’s strong commercial progression with a growing customer base, Q-linea today announced a cost efficiency program to...
Read more >
Interim report 1 January - 30 September 2025
Strong pipeline growth while the installed base of ASTar increases demand for consumablesThe quarter July – September 2025Net sales...
Read more >
Load more